Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × Terminated × Clonidine × Clear all

Phase

Phase EARLY_PHASE1 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Interventions

Magnetic Resonance Spectroscopy 6 Cyclophosphamide 6 pembrolizumab 4 Nivolumab 4 Fluorouracil 4 Carboplatin 4 Biopsy 4 X-Rays 3 Vincristine 3 Radiosurgery 3 Positron-Emission Tomography 3 Cisplatin 3 Blood Specimen Collection 3 Bevacizumab 3 fludarabine phosphate 2 durvalumab 2 atezolizumab 2 Varenicline 2 Topotecan 2 Taxes 2 Surveys and Questionnaires 2 Specimen Handling 2 Rituximab 2 Radiotherapy 2 Proflavine 2 Positron Emission Tomography Computed Tomography 2 Oxaliplatin 2 Metformin 2 Leucovorin 2 Letrozole 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04030572 2021-06-24

a2a Agonist

Weill Medical College of Cornell University

Phase EARLY_PHASE1 Terminated

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡